Cargando…

Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19

BACKGROUND: The Corona Virus Disease 2019(COVID-19) pandemic has strained healthcare systems worldwide, necessitating the early prediction of patients requiring critical care. This study aimed to analyze the laboratory examination indicators, CT features, and prognostic risk factors in COVID-19 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Guobin, Zhu, Yunya, Qiu, Xingting, Yuan, Xiaoliang, Mi, Xiaojing, Zhou, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481600/
https://www.ncbi.nlm.nih.gov/pubmed/37674193
http://dx.doi.org/10.1186/s12890-023-02613-2
_version_ 1785102013861724160
author Wu, Guobin
Zhu, Yunya
Qiu, Xingting
Yuan, Xiaoliang
Mi, Xiaojing
Zhou, Rong
author_facet Wu, Guobin
Zhu, Yunya
Qiu, Xingting
Yuan, Xiaoliang
Mi, Xiaojing
Zhou, Rong
author_sort Wu, Guobin
collection PubMed
description BACKGROUND: The Corona Virus Disease 2019(COVID-19) pandemic has strained healthcare systems worldwide, necessitating the early prediction of patients requiring critical care. This study aimed to analyze the laboratory examination indicators, CT features, and prognostic risk factors in COVID-19 patients. METHODS: A retrospective study was conducted on 90 COVID-19 patients at the First Affiliated Hospital of Gannan Medical University between December 17, 2022, and March 17, 2023. Clinical data, laboratory examination results, and computed tomography (CT) imaging data were collected. Logistic multivariate regression analysis was performed to identify independent risk factors, and the predictive ability of each risk factor was assessed using the area under the receiver operating characteristic (ROC) curve. RESULTS: Multivariate logistic regression analysis revealed that comorbid diabetes (odds ratio [OR] = 526.875, 95%CI = 1.384-1960.84, P = 0.053), lymphocyte count reduction (OR = 8.773, 95%CI = 1.432–53.584, P = 0.064), elevated D-dimer level (OR = 362.426, 95%CI = 1.228-984.995, P = 0.023), and involvement of five lung lobes (OR = 0.926, 95%CI = 0.026–0.686, P = 0.025) were risk factors for progression to severe COVID-19. ROC curve analysis showed the highest predictive value for 5 lung lobes (AUC = 0.782). Oxygen saturation was positively correlated with normally aerated lung volume and the proportion of normally aerated lung volume (P < 0.05). CONCLUSIONS: The study demonstrated that comorbid diabetes, lymphocyte count reduction, elevated D-dimer levels, and involvement of the five lung lobes are significant risk factors for severe COVID-19. In CT lung volume quantification, normal aerated lung volume and the proportion of normal aerated lung volume correlated with blood oxygen saturation.
format Online
Article
Text
id pubmed-10481600
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104816002023-09-07 Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19 Wu, Guobin Zhu, Yunya Qiu, Xingting Yuan, Xiaoliang Mi, Xiaojing Zhou, Rong BMC Pulm Med Research BACKGROUND: The Corona Virus Disease 2019(COVID-19) pandemic has strained healthcare systems worldwide, necessitating the early prediction of patients requiring critical care. This study aimed to analyze the laboratory examination indicators, CT features, and prognostic risk factors in COVID-19 patients. METHODS: A retrospective study was conducted on 90 COVID-19 patients at the First Affiliated Hospital of Gannan Medical University between December 17, 2022, and March 17, 2023. Clinical data, laboratory examination results, and computed tomography (CT) imaging data were collected. Logistic multivariate regression analysis was performed to identify independent risk factors, and the predictive ability of each risk factor was assessed using the area under the receiver operating characteristic (ROC) curve. RESULTS: Multivariate logistic regression analysis revealed that comorbid diabetes (odds ratio [OR] = 526.875, 95%CI = 1.384-1960.84, P = 0.053), lymphocyte count reduction (OR = 8.773, 95%CI = 1.432–53.584, P = 0.064), elevated D-dimer level (OR = 362.426, 95%CI = 1.228-984.995, P = 0.023), and involvement of five lung lobes (OR = 0.926, 95%CI = 0.026–0.686, P = 0.025) were risk factors for progression to severe COVID-19. ROC curve analysis showed the highest predictive value for 5 lung lobes (AUC = 0.782). Oxygen saturation was positively correlated with normally aerated lung volume and the proportion of normally aerated lung volume (P < 0.05). CONCLUSIONS: The study demonstrated that comorbid diabetes, lymphocyte count reduction, elevated D-dimer levels, and involvement of the five lung lobes are significant risk factors for severe COVID-19. In CT lung volume quantification, normal aerated lung volume and the proportion of normal aerated lung volume correlated with blood oxygen saturation. BioMed Central 2023-09-06 /pmc/articles/PMC10481600/ /pubmed/37674193 http://dx.doi.org/10.1186/s12890-023-02613-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Guobin
Zhu, Yunya
Qiu, Xingting
Yuan, Xiaoliang
Mi, Xiaojing
Zhou, Rong
Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19
title Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19
title_full Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19
title_fullStr Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19
title_full_unstemmed Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19
title_short Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19
title_sort application of clinical and ct imaging features in the evaluation of disease progression in patients with covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481600/
https://www.ncbi.nlm.nih.gov/pubmed/37674193
http://dx.doi.org/10.1186/s12890-023-02613-2
work_keys_str_mv AT wuguobin applicationofclinicalandctimagingfeaturesintheevaluationofdiseaseprogressioninpatientswithcovid19
AT zhuyunya applicationofclinicalandctimagingfeaturesintheevaluationofdiseaseprogressioninpatientswithcovid19
AT qiuxingting applicationofclinicalandctimagingfeaturesintheevaluationofdiseaseprogressioninpatientswithcovid19
AT yuanxiaoliang applicationofclinicalandctimagingfeaturesintheevaluationofdiseaseprogressioninpatientswithcovid19
AT mixiaojing applicationofclinicalandctimagingfeaturesintheevaluationofdiseaseprogressioninpatientswithcovid19
AT zhourong applicationofclinicalandctimagingfeaturesintheevaluationofdiseaseprogressioninpatientswithcovid19